Healthcare
CVC to take over 3i's Vedici
Firm enters exclusive negotiations for private hospital group
VC-backed Pixium floats with €100m market cap
Company sold 4.2 million shares at 828 euro cents apiece
Auriga et al. invest €5m in Fab’entech
Company will use funds to expand internationally
Oxford Capital leads $10m round for Oxitec
Biotechnology company seeks to commercialise its dengue mosquito control technology
Nordic Nanovector closes pre-IPO private placement
Oversubscribed placement saw price pushed up to NOK 250m from NOK 150m
VC-backed Abzena plans flotation
No details of flotation have been released
IK divests GHD to Nordic Capital
Nordic Capital Fund VIII used to make transaction
CRB Inverbio takes 50% stake in Mecwins
Madrid-based life sciences specialist Cross Road Biotech Inversiones Biotecnológicas (CRB) has acquired a 50% stake in biotech start-up Mecwins for around €4m.
CVC to buy Doughty's Quirón
Consolidation begins in Spanish hospital market
Inveni, Omega invest €2.5m in BioSilta
Fresh capital to be used for further commercial development
Nixen exits Ceva Santé Animale
Company management and employees to remain majority shareholder
VC-backed arGEN-X announces IPO plans
Plans to offer new shares to raise fresh funding for company
Ardian acquires Bio 7 stake from Chequers Capital
Company to continue with buy-and-build strategy
PAI acquires DomusVi
Deal was sourced through an auction process
Archimed reaches €100m first close for maiden healthcare fund
3i spinout reaches milestone after three months on the road
Sovereign exits Tracscare to G Square
Sovereign first invested in the company in 2004
Cinven sells Partnerships in Care in $660m deal
GP acquired the firm for £552m in 2005
VC-backed Lab21 sold to Novacyt
Lab21 to be wholly absorbed into listed French firm
VC-backed Pixium plans flotation
Company could raise up to €36.6m in IPO
Isis reaps 2.5x on WMS exit
GP originally invested £10.5m in MBO in 2007
Cinven reaps 2.4x on sale of Sebia to Montagu and Astorg
Deal believed to be worth €1-1.2bn
Cambridge Enterprise et al. invest in DefiniGen
Latest £1m investment brings series-A round to a close
Oxford Capital and Finance Wales inject £3.5m into BioMonde
Company to expand into US market
Epidarex raises early-stage UK life sciences fund
Fund received commitments from research universities and Lilly pharmaceutical company